TW200613004A - External preparation of solid/oil type - Google Patents

External preparation of solid/oil type

Info

Publication number
TW200613004A
TW200613004A TW094129900A TW94129900A TW200613004A TW 200613004 A TW200613004 A TW 200613004A TW 094129900 A TW094129900 A TW 094129900A TW 94129900 A TW94129900 A TW 94129900A TW 200613004 A TW200613004 A TW 200613004A
Authority
TW
Taiwan
Prior art keywords
external preparation
solid
oil type
drug
hydrophilic drug
Prior art date
Application number
TW094129900A
Other languages
English (en)
Inventor
Takeru Fujii
Hideakira Yokoyama
Akihiko Hirata
Masahiro Goto
Noriho Kamiya
Original Assignee
Aspion Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aspion Co Ltd filed Critical Aspion Co Ltd
Publication of TW200613004A publication Critical patent/TW200613004A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
TW094129900A 2004-08-31 2005-08-31 External preparation of solid/oil type TW200613004A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004252829 2004-08-31

Publications (1)

Publication Number Publication Date
TW200613004A true TW200613004A (en) 2006-05-01

Family

ID=36000217

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094129900A TW200613004A (en) 2004-08-31 2005-08-31 External preparation of solid/oil type

Country Status (7)

Country Link
US (1) US20090238846A1 (zh)
EP (1) EP1785131A4 (zh)
JP (1) JP4843494B2 (zh)
CN (1) CN101022785A (zh)
IL (1) IL181618A0 (zh)
TW (1) TW200613004A (zh)
WO (1) WO2006025583A1 (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5752343B2 (ja) * 2007-01-24 2015-07-22 株式会社ココカラファインネクスト Ｓ／ｏ型経皮免疫剤
EP2216015A4 (en) * 2007-11-02 2012-12-19 So Pharmaceutical Corp SOLUBLE-AGENT TENSIO-ACTIVE MEDIOCREMENT COMPLEX PRODUCT AND PROCESS FOR PRODUCING THE SAME
WO2009139506A1 (ja) * 2008-05-15 2009-11-19 Ａｓｐｉｏｎ株式会社 異なる物性の薬物の一剤形化
EP2305292A4 (en) * 2008-08-01 2013-02-20 So Pharmaceutical Corp TRANSDERMAL IMMUNIZER OF S / O TYPE
JP2012152655A (ja) * 2011-01-21 2012-08-16 Biomedix:Kk Ｓ／ｏ型サスペンションの製造方法
JP2014172840A (ja) * 2013-03-07 2014-09-22 Lintec Corp 貼付剤
JPWO2016006630A1 (ja) * 2014-07-10 2017-04-27 積水化学工業株式会社 持続性全身作用型外用剤
JP6058604B2 (ja) * 2014-09-19 2017-01-11 積水化学工業株式会社 コアシェル構造体及びそれを含有するｓ／ｏ型サスペンション
JP6097340B2 (ja) * 2015-06-29 2017-03-15 積水化学工業株式会社 製剤
WO2016043323A1 (ja) * 2014-09-19 2016-03-24 積水化学工業株式会社 製剤及びその製造方法
WO2016098857A1 (ja) 2014-12-19 2016-06-23 積水化学工業株式会社 製剤
JP2016117681A (ja) * 2014-12-19 2016-06-30 積水化学工業株式会社 コアシェル構造体を含有する製剤
JP6801646B2 (ja) * 2015-04-14 2020-12-16 日産化学株式会社 ナノ機能性粒子
US10561603B2 (en) 2015-06-29 2020-02-18 Sekisui Chemical Co., Ltd. Core-shell structure and topical agent
WO2017014306A1 (ja) * 2015-07-22 2017-01-26 積水化学工業株式会社 製剤
JP6809784B2 (ja) * 2015-12-21 2021-01-06 積水化学工業株式会社 製剤
US20180318220A1 (en) * 2015-12-25 2018-11-08 Sekisui Chemical Co., Ltd. Particles, pharmaceutical preparation, topical drug, and cosmetic product
JP6212674B1 (ja) * 2015-12-28 2017-10-11 積水化学工業株式会社 外用剤及びその製造方法
JP2018070535A (ja) * 2016-11-01 2018-05-10 積水化学工業株式会社 有効成分含有粒子、製剤、外用薬、化粧品及び注射剤
CN110114061A (zh) * 2016-12-28 2019-08-09 小林制药株式会社 外用组合物
CN109310777B (zh) * 2017-02-09 2021-07-30 积水化学工业株式会社 芯壳结构体、制剂、外用药、胶带剂以及化妆品
JP6842091B2 (ja) * 2017-02-10 2021-03-17 株式会社ツツミプランニング 水溶性分子複合体含有油剤の製造方法、及び分散液の製造方法
JP7039197B2 (ja) * 2017-06-30 2022-03-22 小林製薬株式会社 Ｓ／ｏ型サスペンション及びその製造方法
JP2019069912A (ja) * 2017-10-06 2019-05-09 株式会社シャネル化粧品技術開発研究所 非水系皮膚外用組成物およびその製造方法
JP2019069913A (ja) 2017-10-06 2019-05-09 株式会社シャネル化粧品技術開発研究所 非水系皮膚外用組成物の製造方法
WO2019102992A1 (ja) 2017-11-21 2019-05-31 積水化学工業株式会社 皮膚外用剤
EP3808377A4 (en) * 2018-05-31 2022-03-16 Kyushu University, National University Corporation PREPARATION FOR PERCUTANEOUS ABSORPTION
JP7047672B2 (ja) * 2018-08-29 2022-04-05 東洋インキＳｃホールディングス株式会社 皮膚貼付用粘着剤、該粘着剤を用いた皮膚貼付剤及び剥離用シート状部材付き皮膚用貼付剤の製造方法
TW202102265A (zh) * 2019-03-29 2021-01-16 日商日產化學股份有限公司 卵磷脂ｓ／ｏ製劑之新穎製造方法及其製劑
US20220280437A1 (en) * 2019-09-13 2022-09-08 Sekisui Chemical Co., Ltd. Formulation
JP2021059521A (ja) * 2019-10-09 2021-04-15 積水化学工業株式会社 製剤
WO2021075491A1 (ja) 2019-10-16 2021-04-22 国立大学法人九州大学 経皮吸収型貼付剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1417003A (en) * 1972-06-22 1975-12-10 Radiochemical Centre Ltd Stabilisation of fibrinogen
JPS58150508A (ja) * 1982-03-02 1983-09-07 Mitsubishi Chem Ind Ltd 皮膚用製剤
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IT1229489B (it) * 1988-12-09 1991-09-03 Altergon Sa Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile
US5210099A (en) * 1991-02-11 1993-05-11 American Home Products Corporation Analgesic compositions
JP3526887B2 (ja) * 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
GB9424902D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Solubilisation Aids
JP3802105B2 (ja) * 1995-06-27 2006-07-26 久光メディカル株式会社 ジクロフェナクナトリウム含有乳化外用剤
IT1295369B1 (it) * 1997-10-21 1999-05-12 Fatro Spa Composizione a base di tiamfenicolo e diclofenac
WO2000047203A1 (en) * 1999-02-12 2000-08-17 Mqs, Inc. Formulation and system for intra-oral delivery of pharmaceutical agents
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
WO2000074736A1 (en) * 1999-06-04 2000-12-14 Delrx Pharmaceutical Corporation Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
ES2367541T3 (es) * 2000-04-18 2011-11-04 Hisamitsu Pharmaceutical Co., Inc. Parche que contiene un agente antiinflamatorio.
KR100463167B1 (ko) * 2001-04-13 2004-12-23 주식회사 태평양 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
JP4269078B2 (ja) * 2002-06-03 2009-05-27 宮崎県 Ｓ／ｏ／ｗエマルション及びその製造方法
JP4426749B2 (ja) * 2002-07-11 2010-03-03 株式会社産学連携機構九州 Ｏ／ｗ型エマルション製剤
US6936273B2 (en) * 2002-12-20 2005-08-30 Idexx Laboratories, Inc. Liposomal analgesic formulation and use

Also Published As

Publication number Publication date
EP1785131A1 (en) 2007-05-16
EP1785131A8 (en) 2007-08-01
EP1785131A4 (en) 2009-03-11
CN101022785A (zh) 2007-08-22
WO2006025583A1 (ja) 2006-03-09
US20090238846A1 (en) 2009-09-24
IL181618A0 (en) 2007-07-04
JPWO2006025583A1 (ja) 2008-05-08
JP4843494B2 (ja) 2011-12-21

Similar Documents

Publication Publication Date Title
TW200613004A (en) External preparation of solid/oil type
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
CY1117656T1 (el) Επιλογες θεραπειας για τη νοσο του fabry
WO2006108405A3 (de) Nanopartikel-wirkstoff-konjugate
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
DK1792927T3 (da) Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens
DK1853250T3 (da) Kombinationer og måder til indgivelse af terapeutiske midler og kombinationsterapi
DK1781277T3 (da) Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
EA200901155A1 (ru) Модуляторы фармакокинетических свойств терапевтических препаратов (варианты) и их использование в терапии
DE602005017753D1 (de) Mittel für die transdermale verabreichung von nikotin
DK1771155T3 (da) Fremgangsmåde og sammensætning til behandling af rhinitis
WO2007106284A3 (en) Silicone based emulsions for topical drug delivery
CY1117174T1 (el) ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ
MX2009011900A (es) Curacion de herida diabetica.
HK1120417A1 (en) Stable nanoparticle formulations
EA200801890A1 (ru) Средство для лечения шума в ушах
WO2008098077A3 (en) Substituted alkine derivatives as anti-cancer agents
FR2885128B1 (fr) Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant
WO2004090537A3 (en) Methods to individualize combination therapy
ATE551999T1 (de) P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff
WO2005018569A3 (en) Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin modulating agent for the treatment of neoplasia
WO2008056059A3 (fr) Derives de 4-azasteroles, leurs procedes de synthese et leur utilisation a titre de medicament